Salarius Pharmaceuticals, Inc. (SLRX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | -1.65M | -862.3K | -1.18M | -742.52K | -1.36M | -1.07M | -1.35M | -1.51M | -3.75M | -4.42M | -3.17M | -4.71M | -5.74M | -3.62M | -3.52M | -2.72M | -1.58M | -3.17M | -2.72M | -1.37M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 147.84% | - | -555.63% | -214.59% | -92.87% |
| Operating CF Growth % | -21.38% | 19.58% | 12.72% | 50.87% | 63.81% | 75.72% | 57.28% | 67.94% | 34.7% | -22.01% | 9.98% | -73.26% | -262.9% | -14.01% | -29.31% | -98.08% | 42.54% | -28.18% | 26.57% | 47.91% |
| Net Income | -873.47K | -957.83K | -1.71M | -1.46M | -972.12K | -1.42M | -1.72M | -881.8K | -2.44M | -3.88M | -5.34M | -6.37M | -14.41M | -4.72M | -6.11M | -4.1M | -3.74M | -3.07M | -1.85M | -1.77M |
| Depreciation & Amortization | 1.11K | 1.11K | 1.11K | 1.11K | 1.1K | 1.11K | 1.11K | 1.1K | 5.61K | 1.67K | 1.67K | 1.67K | 1.67K | -1.46K | 4.8K | 4.8K | 4.8K | 4.8K | 4.79K | 5.36K |
| Stock-Based Compensation | 22.85K | 23.16K | 33.53K | 51.05K | 60.01K | 85.17K | 77.51K | 85.38K | 112.66K | 123.46K | 203.34K | 145.51K | 137.87K | 199.53K | 313.9K | 145.89K | 130.32K | 147.46K | 135.38K | 169.73K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -573.37K | 0 | 94.09K | 1.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 573.37K | 130K | -94.09K | -1.9M | -1.88K | 8.87M | 0 | 1.99M | -39.49K | -9.07K | -42.19K | 46.05K | -18.01K |
| Working Capital Changes | -797.17K | 71.27K | 493.18K | 669.26K | -445.67K | 265.97K | 282.72K | -715.91K | -1.55M | -664.27K | 1.97M | 1.51M | -336.74K | 900.65K | 281.8K | 1.27M | 2.03M | -210.48K | -1.06M | 236.99K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.48M | 0 | 0 | 0 | 0 | 475.67K | 2.71M | -571.39K | -367.54K | -643.32K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -310.84K | 83.33K | 254.65K | 771.19K | -453.67K | -94.49K | 111.1K | -485.79K | -1.1M | -1.3M | 627.58K | 1.14M | -72.47K | 95.66K | 150.3K | 308.17K | -40.95K | -131.36K | -446.52K | 605.12K |
| Cash from Investing | -200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.5M | 0 | 0 | 0 | 0 | -2.6K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.5M | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.6K |
| Cash from Financing | 5.86M | -141.2K | 545.57K | -106.98K | 1.37M | -28.19K | -172.75K | -169.45K | -211.83K | 6.68M | 336.68K | 0 | -85.69K | 2.07M | 0 | 31.26K | 406.36K | -358.12K | 28.22M | 2.94M |
| Debt Issued (Net) | 0 | -112.23K | -109.64K | -106.98K | -69.88K | -116.86K | -172.79K | -169.45K | -111.47K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -191.4K | -285.63K | -284.07K |
| Equity Issued (Net) | 0 | -28.97K | 655.2K | 0 | 1000K | 88.67K | 38 | 0 | -100.36K | 1000K | 336.68K | 0 | -85.69K | 1000K | 0 | 31.25K | 406.36K | -166.72K | 1000K | -12K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -86 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 5.86M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 1.49M | 3.23M |
| Net Change in Cash | 4.01M | -1M | -636.15K | -849.5K | 11.21K | -1.1M | -1.53M | -1.68M | -3.96M | 2.27M | -2.83M | -4.71M | -5.83M | -1.55M | -5.02M | -2.69M | -1.18M | -3.53M | 25.49M | 1.56M |
| Free Cash Flow | -1.65M | -862.3K | -1.18M | -742.52K | -1.36M | -1.07M | -1.35M | -1.51M | -3.75M | -4.42M | -3.17M | -4.71M | -5.74M | -3.62M | -5.02M | -2.72M | -1.58M | -3.17M | -2.72M | -1.38M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 147.84% | - | -555.63% | -214.59% | -93.05% |
| FCF Growth % | -21.38% | 19.58% | 12.72% | 50.87% | 63.81% | 75.72% | 57.28% | 67.94% | 34.7% | -22.01% | 36.87% | -73.26% | -262.9% | -14.01% | -84.4% | -97.71% | 42.54% | -28.18% | 26.57% | 47.81% |
| FCF per Share | -3.42 | -6.06 | -10.60 | -11.52 | -15.80 | -26.65 | -38.54 | -45.82 | -119.24 | -194.65 | -158.21 | -249.76 | -304.97 | -201.87 | -324.02 | -179.56 | -105.40 | -211.75 | -266.03 | -197.63 |
| FCF Conversion (FCF/Net Income) | 1.89x | 0.90x | 0.69x | 0.51x | 1.40x | 0.75x | 0.79x | 1.71x | 1.53x | 1.14x | 0.59x | 0.74x | 0.40x | 0.77x | 0.58x | 0.66x | 0.42x | 1.03x | 1.47x | 0.78x |
| Interest Paid | 0 | 1.71K | 0 | -1.42K | 7.25K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.17K | 2.05K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |